Babies With Common Cancer Live as Long With Less Chemotherapy, University of California, San Francisco (UCSF) Study Finds

Bloomberg -- Cutting the amount of chemotherapy in infants and young children with neuroblastoma to reduce the risk of long-term side effects still enabled more than 90 percent to survive the third-most common childhood cancer, a study showed.